Mesoblast (MSB) is held by 16 ASX ETFs. Over the last 3 months it fell 1.5%: on $10,000, −$146. We explain 2 big moves in that time.
About MSB
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$2.6b
- Held by16 ETFs
- Big moves2 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +8.8%15 Jul 2026· Operational
Mesoblast shares surged after the company announced it had enrolled 300 patients in its Phase 3 back pain trial, hitting a key milestone, while continuing momentum from a recent strong Ryoncil commercial launch and FDA BLA progress drove sustained buying interest.
- +7.9%10 Jul 2026· Unknown
Mesoblast shares rose sharply, most likely driven by company-specific news or clinical trial developments not captured in available data sources, as the move is too large to be explained by broad market or sector tailwinds alone.
Held by 16 ETFs
Of every $10,000 in each fund, how much is in MSB today.
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$670.67%
- ISOiShares S&P/ASX Small Ordinaries ETF$660.66%
- FAIRBetaShares Australian Sustainability Leaders ETF$460.46%
- VSOVanguard MSCI Australian Small Companies Index ETF$340.34%
- OZXXGlobal X Australia ex Financials & Resources ETF$270.27%
- EX20BetaShares Australian Ex-20 Portfolio Diversifier ETF$190.19%
- GEARBetaShares Geared Australian Equities Complex ETF$160.16%
- VETHVanguard Ethically Conscious Australian Shares ETF$100.10%
- ROYLBetaShares Global Royalties ETF$8.030.08%
- STWSTATE STREET SPDR S&P/ASX 200 ETF$7.900.08%